Literature DB >> 15889046

Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma.

Anne-Sophie Jannot1, Roubila Meziani, Guylene Bertrand, Benedicte Gérard, Vincent Descamps, Alain Archimbaud, Catherine Picard, Laurence Ollivaud, Nicole Basset-Seguin, Delphine Kerob, Guy Lanternier, Celeste Lebbe, P Saiag, Beatrice Crickx, Françoise Clerget-Darpoux, Bernard Grandchamp, Nadem Soufir.   

Abstract

The occuloalbinism 2 (OCA2) gene, localized at 15q11, encodes a melanosomal transmembrane protein that is involved in the most common form of human occulo-cutaneous albinism, a human genetic disorder characterized by fair pigmentation and susceptibility to skin cancer. We wondered whether allele variations at this locus could influence susceptibility to malignant melanoma (MM). In all, 10 intragenic single-nucleotide polymorphisms (SNPs) were genotyped in 113 patients with melanomas and in 105 Caucasian control subjects with no personal or family history of skin cancer. By comparing allelic distribution between cases and controls, we show that MM and OCA2 are associated (p value=0.030 after correction for multiple testing). Then, a recently developed strategy, the 'combination test' enabled us to show that a combination formed by two SNPs was most strongly associated to MM, suggesting a possible interaction between intragenic SNPs. In addition, the role of OCA2 on MM risk was also detected using a logistic model taking into account the presence of variants of the melanocortin 1 receptor gene (MC1R, a key pigmentation gene) and all pigmentation characteristics as melanoma risk factors. Our data demonstrate that a second pigmentation gene, in addition to MC1R, is involved in genetic susceptibility to melanoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889046     DOI: 10.1038/sj.ejhg.5201415

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  30 in total

1.  Inherited genetic variants associated with occurrence of multiple primary melanoma.

Authors:  David C Gibbs; Irene Orlow; Peter A Kanetsky; Li Luo; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Loraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Ajay Sharma; Emily La Pilla; Lynn From; Klaus J Busam; Anne E Cust; David W Ollila; Colin B Begg; Marianne Berwick; Nancy E Thomas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-04-02       Impact factor: 4.254

2.  A three-single-nucleotide polymorphism haplotype in intron 1 of OCA2 explains most human eye-color variation.

Authors:  David L Duffy; Grant W Montgomery; Wei Chen; Zhen Zhen Zhao; Lien Le; Michael R James; Nicholas K Hayward; Nicholas G Martin; Richard A Sturm
Journal:  Am J Hum Genet       Date:  2006-12-20       Impact factor: 11.025

3.  Oculocutaneous albinism type 2 (OCA2) with homozygous 2.7-kb deletion of the P gene and sickle cell disease in a Cameroonian family. Identification of a common TAG haplotype in the mutated P gene.

Authors:  Robert Aquaron; Nadem Soufir; Jean-Louis Bergé-Lefranc; Catherine Badens; Frederic Austerlitz; Bernard Grandchamp
Journal:  J Hum Genet       Date:  2007-09-01       Impact factor: 3.172

4.  Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.

Authors:  Hongmei Nan; Peter Kraft; David J Hunter; Jiali Han
Journal:  Int J Cancer       Date:  2009-08-15       Impact factor: 7.396

5.  Clinical evaluation and molecular screening of a large consecutive series of albino patients.

Authors:  Lucia Mauri; Emanuela Manfredini; Alessandra Del Longo; Emanuela Veniani; Manuela Scarcello; Roberta Terrana; Adriano Egidio Radaelli; Donata Calò; Giuseppe Mingoia; Antonella Rossetti; Giovanni Marsico; Marco Mazza; Giovanni Pietro Gesu; Maria Cristina Patrosso; Silvana Penco; Elena Piozzi; Paola Primignani
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

6.  Functional annotation of melanoma risk loci identifies novel susceptibility genes.

Authors:  Shenying Fang; Jiachun Lu; Xinke Zhou; Yuling Wang; Merrick I Ross; Jeffrey E Gershenwald; Janice N Cormier; Jennifer Wargo; Dawen Sui; Christopher I Amos; Jeffrey E Lee
Journal:  Carcinogenesis       Date:  2020-06-17       Impact factor: 4.944

7.  Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.

Authors:  Nancy E Thomas; Sharon N Edmiston; Irene Orlow; Peter A Kanetsky; Li Luo; David C Gibbs; Eloise A Parrish; Honglin Hao; Klaus J Busam; Bruce K Armstrong; Anne Kricker; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway
Journal:  J Invest Dermatol       Date:  2018-05-09       Impact factor: 8.551

8.  Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.

Authors:  Xiaohong Rose Yang; Ruth M Pfeiffer; William Wheeler; Meredith Yeager; Stephen Chanock; Margaret A Tucker; Alisa M Goldstein
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

9.  Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma.

Authors:  David L Duffy; Zhen Z Zhao; Richard A Sturm; Nicholas K Hayward; Nicholas G Martin; Grant W Montgomery
Journal:  J Invest Dermatol       Date:  2009-08-27       Impact factor: 8.551

10.  Genomewide association study for onset age in Parkinson disease.

Authors:  Jeanne C Latourelle; Nathan Pankratz; Alexandra Dumitriu; Jemma B Wilk; Stefano Goldwurm; Gianni Pezzoli; Claudio B Mariani; Anita L DeStefano; Cheryl Halter; James F Gusella; William C Nichols; Richard H Myers; Tatiana Foroud
Journal:  BMC Med Genet       Date:  2009-09-22       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.